Navigation Links
IDEXX Laboratories Announces Fourth Quarter and Full Year Results
Date:1/30/2009

quisition-related purchase Accounting and acquisition integration costs (2) - 1,979 - 2,482 Disposition of pharmaceutical product lines and restructuring(3) - - 1,479 - Discrete income tax benefits(4) - - - - Non-GAAP comparative measurements(5) $529,766 $475,639 $173,935 $148,803 % of revenue 51.7% 51.6% 17.0% 16.1% Twelve Months Ended Earnings per Share Net Income Diluted Dec. 31, Dec. 31, Dec. 31, Dec. 31, 2008 2007 2008 2007 GAAP measurement $116,169 $94,014 $1.87 $1.46 % of revenue 11.3% 10.2% Write-downs of certain Pharmaceutical assets (1) - 6,392 - 0.10 Acquisition-related purchase Accounting and acquisition integration costs (2) - 1,588 - 0.02 Disposition of pharmaceutical product lines and restructuring(3) 3,598 - 0.06 Discrete income tax benefits(4) (1,472) - (0.02) - Non-GAAP comparative measurements(5) $118,295 $101,994 $1.90 $1.58 % of revenue 11.6% 11.1% Management believes adjusted diluted EPS is a useful non-GAAP financial measure to evaluate the results of ongoing operations, excluding significant specified events, period over period, and therefore believes that investors may find this information useful in addition to the GAAP results. We use these supplemental n
'/>"/>
SOURCE IDEXX Laboratories, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related medicine news :

1. IDEXX Laboratories to Release 2008 Fourth Quarter and Full-Year Financial Results
2. IDEXX Laboratories Names William Brown Corporate Vice President
3. IDEXX Laboratories to Present at William Blair 28th Annual Growth Stock Conference
4. IDEXX Laboratories to Release 2008 First Quarter Financial Results
5. IDEXX Laboratories Announces Increase in Share Repurchase Program
6. IDEXX Laboratories Announces Fourth Quarter Results
7. IDEXX Laboratories to Release 2007 Fourth Quarter and Full-Year Financial Results
8. IDEXX Laboratories to Present at JPMorgan Healthcare Conference
9. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal 2009
10. Bedford Laboratories(TM) to Begin Shipping Irinotecan HCl Injection
11. Metametrix Announces Acquisition of Accu-Chem Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... 2015 Atagi Plastic Surgery and Skin ... an Ultherapy® Ultra Treatment Provider by Ulthera, ... Aesthetics is one of only six practices in Colorado ... provider. , Atagi Plastic Surgery and Skin Aesthetics’ ... has led the practice to earn the distinction of ...
(Date:6/1/2015)... The Muscular Dystrophy Association is offering an ... the sold out 2015 Bank of America Chicago ... by signing up through the organization's nationwide endurance ... , This national endurance program includes world-class training ... a supportive community of teammates, volunteers, coaches and ...
(Date:6/1/2015)... Note: Dr. Julian is available for interviews ... , A phase III trial funded by the National ... carcinoma in situ (DCIS) now have an additional tool ... (NSABP B-35/NRG Oncology) looked at more than 3,000 DCIS ... with tamoxifen to those who completed five years of ...
(Date:6/1/2015)... (PRWEB) June 01, 2015 Northridge ... are now offering patients a promotion on Invisalign for ... of Invisalign treatment is reduced to $3,700. Patients can ... the complimentary consultation and discuss the extent of correction ... it cannot be combined with any other offer. ...
(Date:6/1/2015)... InstantLabs will co-develop and commercialize a ... a Cooperative Research and Development Agreement (CRADA) with the ... with U.S. Farm Bill legislation, only members of the ... the United States. , InstantLabs’ DNA-based technology will ... need rather than requiring samples be sent to centralized ...
Breaking Medicine News(10 mins):Health News:Atagi Plastic Surgery and Skin Aesthetics Named Ultherapy® Ultra Treatment Provider 2Health News:Sold Out 2015 Bank of America Chicago Marathon and Marine Corps Marathon Entries Still Available through MDA Team Momentum 2Health News:Today at ASCO: Anastrazole Offers Higher Breast Cancer-Free Survival Rates than Tamoxifen Following DCIS, Phase III Study Shows 2Health News:Today at ASCO: Anastrazole Offers Higher Breast Cancer-Free Survival Rates than Tamoxifen Following DCIS, Phase III Study Shows 3Health News:Northridge Dentists, Drs. Michel Elyson and Ramin Assili, are Now Offering a Limited Time Promotion on Invisalign 2Health News:InstantLabs Partners with FDA to Commercialize Catfish Species Identification Test 2Health News:InstantLabs Partners with FDA to Commercialize Catfish Species Identification Test 3Health News:InstantLabs Partners with FDA to Commercialize Catfish Species Identification Test 4
... 2011 Egocentric, self-centred, and insensitive to the needs ... with severe traumatic brain injury (TBI) and have been ... the capacity to recognise and understand the emotions of ... more common, and resulting empathy deficits can have negative ...
... Maryland, June 28, 2011 Nurses on a surgical ... center cut bloodstream infections to zero and saved more ... of Maryland Medical Center SICU sustained a rate of ... period, eliminating 14 CLABSIs and saving 2-3 lives when ...
... from Wayne State University, and her mentor, Lisa J. Rapport, ... Liberal Arts and Sciences, found that if traumatic brain injury ... help them rehabilitate. The study was recently published in ... disruption of normal brain function after a head injury and ...
... Americans and the rest of the nation have been ... blacks who identify as members of the Seventh-day Adventist ... the average American. Researchers point to certain lifestyle behaviors ... was conducted at Loma Linda University as part of ...
... today,s society where access to media is ever present, many ... children and how media consumption can potentially affect them. Two ... and Dr. Michelle M. Garrison, PhD of Seattle Children,s Research ... media usage can lead to depression in college students and ...
... battle to lose inches or at least stay the same, ... 25 and 27 at the American Diabetes Association,s Scientific Sessions ... Epidemiologists from the School of Medicine at The ... showing that diet soft drink consumption is associated with increased ...
Cached Medicine News:Health News:Lack of empathy following traumatic brain injury linked to reduced responsiveness to anger 2Health News:Intensive, hands-on effort reduces bloodstream infections in critically ill patients 2Health News:Religion benefits traumatic brain injury victims, Wayne State University research finds 2Health News:Black members of Adventist church defy health disparities, study shows 2Health News:Studies examine impact of media use among youth, recommend preventative measures 2Health News:Studies examine impact of media use among youth, recommend preventative measures 3Health News:Related studies point to the illusion of the artificial 2Health News:Related studies point to the illusion of the artificial 3
(Date:6/1/2015)... About Pressure Relief Devices ... and improve the quality life of patients who suffer ... a significant role in inhibiting the growth and treatment ... turn or rotate an immobile patient by providing all ... and specialty beds. These devices have the ability to ...
(Date:6/1/2015)... MECHANICSBURG, Pa. , June 1, 2015 ... announced that MJ Acquisition Corporation, a joint venture that ... Stowe XII, L.P., has completed its previously announced acquisition ... in the new joint venture. About ... leading operator of specialty hospitals and outpatient rehabilitation clinics ...
(Date:6/1/2015)... MENLO PARK, Calif. , June ... (OTCQX: DMPI) ("DelMar" and the "Company"), a ... cancer therapies in new orphan drug indications, today ... clinical trial of  VAL-083  (dianhydrogalactitol) in patients with ... deadly form of human brain cancer. ...
Breaking Medicine Technology:Global Pressure Relief Devices Market 2015-2019 2Global Pressure Relief Devices Market 2015-2019 3Select Medical Holdings Corporation Announces Completion of Acquisition of Concentra Inc. through Joint Venture with Welsh Carson 2Select Medical Holdings Corporation Announces Completion of Acquisition of Concentra Inc. through Joint Venture with Welsh Carson 3DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 2DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 3DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 4DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 5DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 6DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 7DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 8